Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
Recruiting · NCT07557706 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Alabama at Birmingham
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The purpose of this study is to find out whether a type of gentle nerve stimulation, called transcutaneous auricular Vagus Nerve Stimulation (taVNS), can help improve how the body regulates heart rate and blood pressure in people with Parkinson's Disease (PD). Problems with heart rate and blood pressure control are common and can make it harder for people to exercise or do daily activities. By using this non-invasive form of nerve stimulation and testing how it affects the body's natural responses, this study hopes to learn if taVNS could be a helpful tool to support physical therapy and improve overall function.
Who can take part
Inclusion criteria
- Diagnosis of idiopathic PD
- Stable medication for at least 4 weeks prior to the study
Exclusion criteria
- Use of beta blockers
- Sustained severe hypertension (\>/= 180/110 mmHg while seated)
- Significant uncontrolled cardiac arrhythmia
- Unstable angina
- Congestive heart failure
- History of myocardial infarction
- History of seizures
- Severe cognitive impairment
- Pregnant women or women who are planning to become pregnant
Where it is running
1 location listed across 1 US state.
- Wellness, Health and Research Facility at UAB - Birmingham, Alabama, United States